Similar results were obtained in other breast cancer cell lines including T-47D (ER+, PR+/-, HER2-), MDA-MB-453 (ER-, PR-, HER2+), MDAMB-134 (ER+, PR-, HER2-) (Figure 1). This evidence concerns the gene PGR and breast cancer.